• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食用含合成大麻素的布朗尼导致的急性中毒群集现象。

Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies.

作者信息

Obafemi Adebisi I, Kleinschmidt Kurt, Goto Collin, Fout Drew

机构信息

UT Southwestern Medical Center, Dallas, TX, USA.

Texas Department of Public Safety, Garland, TX, USA.

出版信息

J Med Toxicol. 2015 Dec;11(4):426-9. doi: 10.1007/s13181-015-0482-z.

DOI:10.1007/s13181-015-0482-z
PMID:25967137
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4675604/
Abstract

INTRODUCTION

Synthetic cannabinoid receptor agonists (SCRAs) are emerging designer drugs of abuse. Most reports on the health effects of these drugs are case reports. Unlike SCRAs, marijuana has classically been used via many routes of exposure including oral, such as in brownies. We report on 11 symptomatic patients who unknowingly ingested brownies laced with analytically confirmed SCRA and presented with mostly neuropsychiatric and cardiovascular symptoms.

CASE SERIES

All 11 patients were taken to the ED within 1 h of exposure with the onset of various symptoms. There were five males and six females, age range 20-57 years. Neuropsychiatric and cardiovascular symptoms predominated: memory impairment (91 %, 10/11) and inappropriate giggling (36 %, 4/11). All the patients had light-headedness, perioral and facial numbness and tingling sensation, dry mouth, difficulty focusing/blurring of vision, and sluggishness. No patient had depressed consciousness. Two patients had heart rates >100, and 4 of 11 (36 %) had BP >140/80. One patient had chest pain. All the symptoms were completely resolved 4 h following their onset except two patients who had ongoing weakness and fatigue. All patients had negative urine drugs of abuse immunoassays and ethanol, acetaminophen, and salicylate concentrations, as well as normal electrocardiograms (ECGS) and metabolic panels. The SCRA was confirmed to be AM-2201. All the patients were discharged from the ED in stable condition within 10 h of the exposure.

CONCLUSION

Oral exposure of 11 patients to brownies laced with analytically confirmed SCRA resulted in neuropsychiatric and cardiovascular symptoms. This series reflects that like marijuana, oral exposures to SCRAs can lead to symptoms.

摘要

引言

合成大麻素受体激动剂(SCRAs)是新出现的滥用设计药物。关于这些药物对健康影响的大多数报告都是病例报告。与SCRAs不同,大麻传统上有多种给药途径,包括口服,比如做成布朗尼蛋糕。我们报告了11例有症状的患者,他们在不知情的情况下食用了经分析确认含有SCRAs的布朗尼蛋糕,主要表现为神经精神和心血管症状。

病例系列

所有11例患者在接触后1小时内因出现各种症状被送往急诊科。其中男性5例,女性6例,年龄在20至57岁之间。以神经精神和心血管症状为主:记忆障碍(91%,10/11)和不适当的傻笑(36%,4/11)。所有患者均有头晕、口周和面部麻木及刺痛感、口干、注意力不集中/视力模糊和反应迟钝。没有患者意识不清。2例患者心率>100,11例中有4例(36%)血压>140/80。1例患者有胸痛。所有症状在出现后4小时完全缓解,除了2例患者仍有持续的虚弱和疲劳。所有患者的尿液滥用药物免疫分析、乙醇、对乙酰氨基酚和水杨酸盐浓度均为阴性,心电图(ECG)和代谢指标也正常。经确认,该SCRAs为AM - 2201。所有患者在接触后10小时内从急诊科出院,病情稳定。

结论

11例患者口服含有经分析确认的SCRAs的布朗尼蛋糕后出现神经精神和心血管症状。该系列病例表明,与大麻一样,口服SCRAs也会引发症状。

相似文献

1
Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies.食用含合成大麻素的布朗尼导致的急性中毒群集现象。
J Med Toxicol. 2015 Dec;11(4):426-9. doi: 10.1007/s13181-015-0482-z.
2
Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.经分析确认使用合成大麻素受体激动剂MDMB-CHMICA后的临床毒性。来自新型精神活性物质识别(IONA)研究的报告。
Clin Toxicol (Phila). 2016 Sep;54(8):638-43. doi: 10.1080/15563650.2016.1190980. Epub 2016 Jun 2.
3
Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists: a report from the United Kingdom National Poisons Information Service.合成大麻素受体激动剂娱乐性使用后中毒的流行病学及临床特征:来自英国国家毒物信息服务中心的报告
Clin Toxicol (Phila). 2016 Jul;54(6):512-8. doi: 10.3109/15563650.2016.1171329. Epub 2016 Apr 19.
4
Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): a retrospective cohort study of presentations with acute toxicity to European hospitals between 2013 and 2020.与合成大麻素受体激动剂(SCRAs)相比大麻的临床效果:2013 年至 2020 年间欧洲医院急性毒性就诊的回顾性队列研究。
Clin Toxicol (Phila). 2024 Jun;62(6):378-384. doi: 10.1080/15563650.2024.2346125. Epub 2024 Jun 27.
5
Suspected synthetic cannabinoid receptor agonist intoxication: Does analysis of samples reflect the presence of suspected agents?疑似合成大麻素受体激动剂中毒:样本分析是否反映出疑似药物的存在?
Am J Emerg Med. 2019 Oct;37(10):1846-1849. doi: 10.1016/j.ajem.2018.12.044. Epub 2018 Dec 24.
6
The impact of Australian legislative changes on synthetic cannabinoid exposures reported to the New South Wales Poisons Information Centre.澳大利亚立法变化对新南威尔士毒物信息中心报告的合成大麻素暴露的影响。
Int J Drug Policy. 2017 May;43:74-82. doi: 10.1016/j.drugpo.2017.02.008. Epub 2017 Mar 23.
7
Clinical Effects of Synthetic Cannabinoid Receptor Agonists Compared with Marijuana in Emergency Department Patients with Acute Drug Overdose.合成大麻素受体激动剂与大麻对急诊科急性药物过量患者的临床效果比较
J Med Toxicol. 2016 Dec;12(4):335-340. doi: 10.1007/s13181-016-0558-4. Epub 2016 Jun 2.
8
Evolution of clinical characteristics and outcomes of synthetic cannabinoid receptor agonist exposure in the United States: analysis of National Poison Data System data from 2010 to 2015.美国合成大麻素受体激动剂暴露的临床特征和结局演变:2010 至 2015 年国家毒物数据系统数据的分析。
Addiction. 2018 Oct;113(10):1850-1861. doi: 10.1111/add.14281. Epub 2018 Jun 27.
9
Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011-2014.2011年至2014年向纽约市中毒控制中心报告的新型精神活性物质暴露特征。
Am J Drug Alcohol Abuse. 2016;42(1):39-47. doi: 10.3109/00952990.2015.1106551. Epub 2015 Dec 17.
10
Spicing it up - synthetic cannabinoid receptor agonists and psychosis - a systematic review.来点刺激的 - 合成大麻素受体激动剂与精神病 - 系统综述。
Eur Neuropsychopharmacol. 2018 Dec;28(12):1289-1304. doi: 10.1016/j.euroneuro.2018.10.004. Epub 2018 Nov 16.

引用本文的文献

1
The synthetic cannabinoids menace: a review of health risks and toxicity.合成大麻素的威胁:健康风险和毒性综述。
Eur J Med Res. 2024 Jan 12;29(1):49. doi: 10.1186/s40001-023-01443-6.
2
In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice.在体生物激活 JWH-175 为 JWH-018:在小鼠中的药效学和药代动力学研究。
Int J Mol Sci. 2022 Jul 21;23(14):8030. doi: 10.3390/ijms23148030.
3
Prevalence and characteristics of cannabis-induced toxicoses in pets: Results from a survey of veterinarians in North America.宠物中大麻中毒的流行情况和特征:对北美的兽医进行调查的结果。
PLoS One. 2022 Apr 20;17(4):e0261909. doi: 10.1371/journal.pone.0261909. eCollection 2022.
4
Primary Causes of Hospitalizations and Procedures, Predictors of In-hospital Mortality, and Trends in Cardiovascular and Cerebrovascular Events Among Recreational Marijuana Users: A Five-year Nationwide Inpatient Assessment in the United States.娱乐性大麻使用者的住院和手术主要原因、院内死亡率预测因素以及心血管和脑血管事件趋势:美国一项为期五年的全国性住院患者评估
Cureus. 2018 Aug 23;10(8):e3195. doi: 10.7759/cureus.3195.
5
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.大麻和合成大麻素对心血管的影响:有好有坏,也有丑。
Nat Rev Cardiol. 2018 Mar;15(3):151-166. doi: 10.1038/nrcardio.2017.130. Epub 2017 Sep 14.
6
Role of cannabis in cardiovascular disorders.大麻在心血管疾病中的作用。
J Thorac Dis. 2017 Jul;9(7):2079-2092. doi: 10.21037/jtd.2017.06.104.
7
Emerging drugs of abuse: current perspectives on synthetic cannabinoids.新型滥用药物:合成大麻素的当前观点
Subst Abuse Rehabil. 2015 Oct 20;6:113-29. doi: 10.2147/SAR.S73586. eCollection 2015.

本文引用的文献

1
Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.合成大麻素:流行病学、药效学及临床意义。
Drug Alcohol Depend. 2014 Nov 1;144:12-41. doi: 10.1016/j.drugalcdep.2014.08.005. Epub 2014 Aug 18.
2
Emerging drugs of abuse: clinical and legal considerations.新型滥用药物:临床与法律考量
R I Med J (2013). 2014 Jun 2;97(6):41-5.
3
A survey of synthetic cannabinoid consumption by current cannabis users.当前大麻使用者对合成大麻素消费情况的调查。
Subst Abus. 2014;35(2):184-9. doi: 10.1080/08897077.2013.846288.
4
Smoking synthetic marijuana leads to self-mutilation requiring bilateral amputations.
Orthopedics. 2014 Apr;37(4):e391-4. doi: 10.3928/01477447-20140401-62.
5
"Not for human consumption": a review of emerging designer drugs.“不得供人食用”:新型合成毒品综述
Pharmacotherapy. 2014 Jul;34(7):745-57. doi: 10.1002/phar.1424. Epub 2014 Apr 8.
6
Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order.管制物质清单:将四种合成大麻素临时列入第一类。最终命令。
Fed Regist. 2014 Feb 10;79(27):7577-82.
7
An outbreak of exposure to a novel synthetic cannabinoid.新型合成大麻素暴露事件。
N Engl J Med. 2014 Jan 23;370(4):389-90. doi: 10.1056/NEJMc1313655.
8
The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.K2/Spice 现象:草药香料产品中合成大麻素的出现、鉴定、立法和代谢特征。
Drug Metab Rev. 2014 Feb;46(1):72-85. doi: 10.3109/03602532.2013.839700. Epub 2013 Sep 24.
9
Spicing things up: synthetic cannabinoids.来点刺激的:合成大麻素。
Psychopharmacology (Berl). 2013 Aug;228(4):525-40. doi: 10.1007/s00213-013-3188-4. Epub 2013 Jul 9.
10
Acute intoxication caused by a synthetic cannabinoid in two adolescents.两名青少年因合成大麻素导致急性中毒。
J Pediatr Pharmacol Ther. 2012 Apr;17(2):177-81. doi: 10.5863/1551-6776-17.2.177.